Global control of aberrant splice-site activation by auxiliary splicing sequences:: evidence for a gradient in exon and intron definition

被引:59
作者
Kralovicova, Jana [1 ]
Vorechovsky, Igor [1 ]
机构
[1] Univ Southampton, Sch Med, Div Human Genet, Southampton SO16 6YD, Hants, England
关键词
D O I
10.1093/nar/gkm680
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Auxiliary splicing signals play a major role in the regulation of constitutive and alternative pre-mRNA splicing, but their relative importance in selection of mutation-induced cryptic or de novo splice sites is poorly understood. Here, we show that exonic sequences between authentic and aberrant splice sites that were activated by splice-site mutations in human disease genes have lower frequencies of splicing enhancers and higher frequencies of splicing silencers than average exons. Conversely, sequences between authentic and intronic aberrant splice sites have more enhancers and less silencers than average introns. Exons that were skipped as a result of splice-site mutations were smaller, had lower SF2/ASF motif scores, a decreased availability of decoy splice sites and a higher density of silencers than exons in which splice-site mutation activated cryptic splice sites. These four variables were the strongest predictors of the two aberrant splicing events in a logistic regression model. Elimination or weakening of predicted silencers in two reporters consistently promoted use of intron-proximal splice sites if these elements were maintained at their original positions, with their modular combinations producing expected modification of splicing. Together, these results show the existence of a gradient in exon and intron definition at the level of pre-mRNA splicing and provide a basis for the development of computational tools that predict aberrant splicing outcomes.
引用
收藏
页码:6399 / 6413
页数:15
相关论文
共 63 条
[1]
Bannai Hideo, 2002, Genome Inform, V13, P3
[2]
Brand K, 1996, J LIPID RES, V37, P1213
[3]
Influence of RNA secondary structure on the pre-mRNA splicing process [J].
Buratti, E ;
Baralle, FE .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (24) :10505-10514
[4]
Aberrant 5′ splice sites in human disease genes:: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization [J].
Buratti, Emanuele ;
Chivers, Martin ;
Kralovicova, Jana ;
Romano, Maurizio ;
Baralle, Marco ;
Krainer, Adrian R. ;
Vorechovsky, Igor .
NUCLEIC ACIDS RESEARCH, 2007, 35 (13) :4250-4263
[5]
RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events [J].
Buratti, Emanuele ;
Dhir, Ashish ;
Lewandowska, Marzena A. ;
Baralle, Francisco E. .
NUCLEIC ACIDS RESEARCH, 2007, 35 (13) :4369-4383
[6]
Defective splicing, disease and therapy: searching for master checkpoints in exon definition [J].
Buratti, Emanuele ;
Baralle, Marco ;
Baralle, Francisco E. .
NUCLEIC ACIDS RESEARCH, 2006, 34 (12) :3494-3510
[7]
RNA-BINDING SPECIFICITY OF HNRNP A1 - SIGNIFICANCE OF HNRNP A1 HIGH-AFFINITY BINDING-SITES IN PRE-MESSENGER-RNA SPLICING [J].
BURD, CG ;
DREYFUSS, G .
EMBO JOURNAL, 1994, 13 (05) :1197-1204
[8]
Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H′/F/2H9 family [J].
Caputi, M ;
Zahler, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (47) :43850-43859
[9]
Comparative analysis detects dependencies among the 5′ splice-site positions [J].
Carmel, I ;
Tal, S ;
Vig, I ;
Ast, G .
RNA, 2004, 10 (05) :828-840
[10]
Listening to silence and understanding nonsense: Exonic mutations that affect splicing [J].
Cartegni, L ;
Chew, SL ;
Krainer, AR .
NATURE REVIEWS GENETICS, 2002, 3 (04) :285-298